Breast cancer Posts on Medivizor
Navigation Menu

Breast cancer Posts on Medivizor

Is nab-paclitaxel a better option than standard solvent-based taxanes for women with breast cancer?

Is nab-paclitaxel a better option than standard solvent-based taxanes for women with breast cancer?

Posted by on Feb 28, 2021 in Breast cancer | 0 comments

In a nutshell This study explored whether nanoparticle albumin-bound (nab) paclitaxel (Abraxane) is more efficient as chemotherapy before surgery compared to solvent-based (sb) taxanes in patients with breast cancer. The authors found that nab-paclitaxel was able to improve the outcomes of these patients. Some background Breast cancer...

Read More

Can a healthy diet improve quality of life of women with breast cancer undergoing chemotherapy?

Can a healthy diet improve quality of life of women with breast cancer undergoing chemotherapy?

Posted by on Feb 28, 2021 in Breast cancer | 0 comments

In a nutshell This study examined whether a healthy diet can improve the quality of life of women with breast cancer undergoing chemotherapy. The authors found that women who followed healthy dietary advice had an improvement in the quality of their life during chemotherapy, reducing nausea, vomiting, and increasing appetite.  Some background...

Read More

Evaluating the effectiveness and safety of stereotactic ablative body radiotherapy in advanced cancer

Evaluating the effectiveness and safety of stereotactic ablative body radiotherapy in advanced cancer

Posted by on Feb 26, 2021 in Breast cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of stereotactic ablative radiation therapy (SABR) in the treatment of patients with oligometastatic (few metastases) cancer. The data showed that the use of SABR in these patients was associated with high overall survival and low toxicity. Some background Oligometastatic cancer (OMC)...

Read More

Is heart monitoring needed in patients with HER2-positive metastatic breast cancer using trastuzumab?

Is heart monitoring needed in patients with HER2-positive metastatic breast cancer using trastuzumab?

Posted by on Feb 20, 2021 in Breast cancer | 0 comments

In a nutshell This article looked at the occurrence of heart-related side effects in patients with HER2-positive metastatic breast cancer (mBC) receiving trastuzumab (Herceptin). The authors found that non-smoking patients with a good heart function before receiving treatment have a low risk of heart toxicity (HT) after 4 years...

Read More

Comparing partial breast irradiation and whole breast irradiation in patients with breast cancer

Comparing partial breast irradiation and whole breast irradiation in patients with breast cancer

Posted by on Feb 14, 2021 in Breast cancer | 0 comments

In a nutshell This article looked at the use of partial breast irradiation (PBI) versus whole-breast irradiation (WBI) as a treatment for breast cancer (BC). The authors found that PBI offered similar results when compared to WBI.  Some background BC remains one of the most common forms of cancer found in women. Standard care for BC remains...

Read More

Can circulating tumor cells help in improving the outcomes of patients with breast cancer?

Can circulating tumor cells help in improving the outcomes of patients with breast cancer?

Posted by on Feb 6, 2021 in Breast cancer | 0 comments

In a nutshell This study evaluated the role of circulating tumor cells (CTCs) in deciding adjuvant therapy (AT; treatment after surgery) in patients with breast cancer (BC). This study showed that personalized AT based on CTCs improved patient survival. Some background BC that has not spread to other areas of the body is called non-metastatic...

Read More

Does the histological grade of early stage breast cancer effect outcomes of older women treated with breast conserving surgery?

Does the histological grade of early stage breast cancer effect outcomes of older women treated with breast conserving surgery?

Posted by on Jan 31, 2021 in Breast cancer | 0 comments

In a nutshell This article was carried out to look at how histological grade (HG) impacts the outcomes of older women with early-stage (ES) breast cancer (BC) treated with breast-conserving therapy (BCS) with or without radiotherapy (RT). The authors found that the treatment of ESBC without RT resulted in a lower cancer-specific survival...

Read More

Reviewing treatments for genitourinary symptoms in breast cancer survivors

Reviewing treatments for genitourinary symptoms in breast cancer survivors

Posted by on Jan 31, 2021 in Breast cancer | 0 comments

In a nutshell This review aims to discuss the current treatment options available for genitourinary (GU) symptoms related to menopause in breast cancer (BC) survivors.  Some background Vulvovaginal atrophy (VVA; thinning, trying, and inflammation of the lining of the vagina) is one of the side effects of hormonal treatments given to patients with...

Read More